MYD88 and lymphoma: Another previous study demonstrated the formation of a multiprotein supercomplex composed of MYD88, TLR9, and the BCR (My-T-BCR) as a mode of oncogenic BCR signaling in various lymphomas, yet this was not evident in CLL LN biopsies [47].